Trancura Biosciences

Trancura Biosciences is a US-based biotechnology company that uses targeted genomic approaches for the de novo design of monoclonal antibodies. The company develops efficient screenings based on molecular immune profiling to accelerate the discovery of new monoclonal antibodies for biomedical relevant molecular targets. Using this approach, the company focuses on the discovery and characterization of antibodies with the potential to treat neurodegenerative diseases and cancer.